Abstract
Summary
A locally absorbable hemostatic, consists of an absorbable sponge, foam, pad, or other material combined with a local hemostatic and then applied to the bleeding site.
LPI (LP Information)' newest research report, the “Topical Absorbable Hemostat Industry Forecast” looks at past sales and reviews total world Topical Absorbable Hemostat sales in 2022, providing a comprehensive analysis by region and market sector of projected Topical Absorbable Hemostat sales for 2023 through 2029. With Topical Absorbable Hemostat sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Topical Absorbable Hemostat industry.
This Insight Report provides a comprehensive analysis of the global Topical Absorbable Hemostat landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Topical Absorbable Hemostat portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms' unique position in an accelerating global Topical Absorbable Hemostat market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Topical Absorbable Hemostat and breaks down the forecast by type, by application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Topical Absorbable Hemostat.
The global Topical Absorbable Hemostat market size is projected to grow from US$ million in 2022 to US$ million in 2029; it is expected to grow at a CAGR of % from 2023 to 2029.
A locally absorbable hemostatic, also known as a passive hemostatic, consists of an absorbable sponge, foam, pad, or other material combined with a local hemostatic and then applied to the bleeding site.
This report presents a comprehensive overview, market shares, and growth opportunities of Topical Absorbable Hemostat market by product type, application, key manufacturers and key regions and countries.
Market Segmentation:
Segmentation by type
Combination Hemostats – Pads
Oxidized Regenerated Cellulose Based Hemostats
Polysaccharide Based Hemostats
Gelatin Based Hemostats
Collagen Based Hemostats
Others
Segmentation by application
Surgery
First-aid
Health Care
This report also splits the market by region:
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries
The below companies that are profiled have been selected based on inputs gathered from primary experts and analyzing the company's coverage, product portfolio, its market penetration.
3-D Matrix Ltd
Angiotech Pharmaceuticals Inc
Anika Therapeutics Inc
APRUS Bio-Medical Innovations Pvt Ltd
Arch Therapeutics Inc
Baxter
C.R. Bard
Cellphire Inc
Covalon Technologies Ltd
Cresilon Inc
Endomedix Incorporated
Entegrion Inc
Ethicon
ETX Pharma Inc
Gelita
Pfizer
Key Questions Addressed in this Report
What is the 10-year outlook for the global Topical Absorbable Hemostat market?
What factors are driving Topical Absorbable Hemostat market growth, globally and by region?
Which technologies are poised for the fastest growth by market and region?
How do Topical Absorbable Hemostat market opportunities vary by end market size?
How does Topical Absorbable Hemostat break out type, application?
What are the influences of COVID-19 and Russia-Ukraine war?
LPI (LP Information)' newest research report, the “Topical Absorbable Hemostat Industry Forecast” looks at past sales and reviews total world Topical Absorbable Hemostat sales in 2022, providing a comprehensive analysis by region and market sector of projected Topical Absorbable Hemostat sales for 2023 through 2029. With Topical Absorbable Hemostat sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Topical Absorbable Hemostat industry.
This Insight Report provides a comprehensive analysis of the global Topical Absorbable Hemostat landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Topical Absorbable Hemostat portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms' unique position in an accelerating global Topical Absorbable Hemostat market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Topical Absorbable Hemostat and breaks down the forecast by type, by application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Topical Absorbable Hemostat.
The global Topical Absorbable Hemostat market size is projected to grow from US$ million in 2022 to US$ million in 2029; it is expected to grow at a CAGR of % from 2023 to 2029.
A locally absorbable hemostatic, also known as a passive hemostatic, consists of an absorbable sponge, foam, pad, or other material combined with a local hemostatic and then applied to the bleeding site.
This report presents a comprehensive overview, market shares, and growth opportunities of Topical Absorbable Hemostat market by product type, application, key manufacturers and key regions and countries.
Market Segmentation:
Segmentation by type
Combination Hemostats – Pads
Oxidized Regenerated Cellulose Based Hemostats
Polysaccharide Based Hemostats
Gelatin Based Hemostats
Collagen Based Hemostats
Others
Segmentation by application
Surgery
First-aid
Health Care
This report also splits the market by region:
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries
The below companies that are profiled have been selected based on inputs gathered from primary experts and analyzing the company's coverage, product portfolio, its market penetration.
3-D Matrix Ltd
Angiotech Pharmaceuticals Inc
Anika Therapeutics Inc
APRUS Bio-Medical Innovations Pvt Ltd
Arch Therapeutics Inc
Baxter
C.R. Bard
Cellphire Inc
Covalon Technologies Ltd
Cresilon Inc
Endomedix Incorporated
Entegrion Inc
Ethicon
ETX Pharma Inc
Gelita
Pfizer
Key Questions Addressed in this Report
What is the 10-year outlook for the global Topical Absorbable Hemostat market?
What factors are driving Topical Absorbable Hemostat market growth, globally and by region?
Which technologies are poised for the fastest growth by market and region?
How do Topical Absorbable Hemostat market opportunities vary by end market size?
How does Topical Absorbable Hemostat break out type, application?
What are the influences of COVID-19 and Russia-Ukraine war?
Table of Contents
1 Scope of the Report
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 Executive Summary
2.1 World Market Overview
2.1.1 Global Topical Absorbable Hemostat Annual Sales 2018-2029
2.1.2 World Current & Future Analysis for Topical Absorbable Hemostat by Geographic Region, 2018, 2022 & 2029
2.1.3 World Current & Future Analysis for Topical Absorbable Hemostat by Country/Region, 2018, 2022 & 2029
2.2 Topical Absorbable Hemostat Segment by Type
2.2.1 Combination Hemostats – Pads
2.2.2 Oxidized Regenerated Cellulose Based Hemostats
2.2.3 Polysaccharide Based Hemostats
2.2.4 Gelatin Based Hemostats
2.2.5 Collagen Based Hemostats
2.2.6 Others
2.3 Topical Absorbable Hemostat Sales by Type
2.3.1 Global Topical Absorbable Hemostat Sales Market Share by Type (2018-2023)
2.3.2 Global Topical Absorbable Hemostat Revenue and Market Share by Type (2018-2023)
2.3.3 Global Topical Absorbable Hemostat Sale Price by Type (2018-2023)
2.4 Topical Absorbable Hemostat Segment by Application
2.4.1 Surgery
2.4.2 First-aid
2.4.3 Health Care
2.5 Topical Absorbable Hemostat Sales by Application
2.5.1 Global Topical Absorbable Hemostat Sale Market Share by Application (2018-2023)
2.5.2 Global Topical Absorbable Hemostat Revenue and Market Share by Application (2018-2023)
2.5.3 Global Topical Absorbable Hemostat Sale Price by Application (2018-2023)
3 Global Topical Absorbable Hemostat by Company
3.1 Global Topical Absorbable Hemostat Breakdown Data by Company
3.1.1 Global Topical Absorbable Hemostat Annual Sales by Company (2018-2023)
3.1.2 Global Topical Absorbable Hemostat Sales Market Share by Company (2018-2023)
3.2 Global Topical Absorbable Hemostat Annual Revenue by Company (2018-2023)
3.2.1 Global Topical Absorbable Hemostat Revenue by Company (2018-2023)
3.2.2 Global Topical Absorbable Hemostat Revenue Market Share by Company (2018-2023)
3.3 Global Topical Absorbable Hemostat Sale Price by Company
3.4 Key Manufacturers Topical Absorbable Hemostat Producing Area Distribution, Sales Area, Product Type
3.4.1 Key Manufacturers Topical Absorbable Hemostat Product Location Distribution
3.4.2 Players Topical Absorbable Hemostat Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2018-2023)
3.6 New Products and Potential Entrants
3.7 Mergers & Acquisitions, Expansion
4 World Historic Review for Topical Absorbable Hemostat by Geographic Region
4.1 World Historic Topical Absorbable Hemostat Market Size by Geographic Region (2018-2023)
4.1.1 Global Topical Absorbable Hemostat Annual Sales by Geographic Region (2018-2023)
4.1.2 Global Topical Absorbable Hemostat Annual Revenue by Geographic Region (2018-2023)
4.2 World Historic Topical Absorbable Hemostat Market Size by Country/Region (2018-2023)
4.2.1 Global Topical Absorbable Hemostat Annual Sales by Country/Region (2018-2023)
4.2.2 Global Topical Absorbable Hemostat Annual Revenue by Country/Region (2018-2023)
4.3 Americas Topical Absorbable Hemostat Sales Growth
4.4 APAC Topical Absorbable Hemostat Sales Growth
4.5 Europe Topical Absorbable Hemostat Sales Growth
4.6 Middle East & Africa Topical Absorbable Hemostat Sales Growth
5 Americas
5.1 Americas Topical Absorbable Hemostat Sales by Country
5.1.1 Americas Topical Absorbable Hemostat Sales by Country (2018-2023)
5.1.2 Americas Topical Absorbable Hemostat Revenue by Country (2018-2023)
5.2 Americas Topical Absorbable Hemostat Sales by Type
5.3 Americas Topical Absorbable Hemostat Sales by Application
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Topical Absorbable Hemostat Sales by Region
6.1.1 APAC Topical Absorbable Hemostat Sales by Region (2018-2023)
6.1.2 APAC Topical Absorbable Hemostat Revenue by Region (2018-2023)
6.2 APAC Topical Absorbable Hemostat Sales by Type
6.3 APAC Topical Absorbable Hemostat Sales by Application
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 China Taiwan
7 Europe
7.1 Europe Topical Absorbable Hemostat by Country
7.1.1 Europe Topical Absorbable Hemostat Sales by Country (2018-2023)
7.1.2 Europe Topical Absorbable Hemostat Revenue by Country (2018-2023)
7.2 Europe Topical Absorbable Hemostat Sales by Type
7.3 Europe Topical Absorbable Hemostat Sales by Application
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 Middle East & Africa
8.1 Middle East & Africa Topical Absorbable Hemostat by Country
8.1.1 Middle East & Africa Topical Absorbable Hemostat Sales by Country (2018-2023)
8.1.2 Middle East & Africa Topical Absorbable Hemostat Revenue by Country (2018-2023)
8.2 Middle East & Africa Topical Absorbable Hemostat Sales by Type
8.3 Middle East & Africa Topical Absorbable Hemostat Sales by Application
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 Market Drivers, Challenges and Trends
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 Manufacturing Cost Structure Analysis
10.1 Raw Material and Suppliers
10.2 Manufacturing Cost Structure Analysis of Topical Absorbable Hemostat
10.3 Manufacturing Process Analysis of Topical Absorbable Hemostat
10.4 Industry Chain Structure of Topical Absorbable Hemostat
11 Marketing, Distributors and Customer
11.1 Sales Channel
11.1.1 Direct Channels
11.1.2 Indirect Channels
11.2 Topical Absorbable Hemostat Distributors
11.3 Topical Absorbable Hemostat Customer
12 World Forecast Review for Topical Absorbable Hemostat by Geographic Region
12.1 Global Topical Absorbable Hemostat Market Size Forecast by Region
12.1.1 Global Topical Absorbable Hemostat Forecast by Region (2024-2029)
12.1.2 Global Topical Absorbable Hemostat Annual Revenue Forecast by Region (2024-2029)
12.2 Americas Forecast by Country
12.3 APAC Forecast by Region
12.4 Europe Forecast by Country
12.5 Middle East & Africa Forecast by Country
12.6 Global Topical Absorbable Hemostat Forecast by Type
12.7 Global Topical Absorbable Hemostat Forecast by Application
13 Key Players Analysis
13.1 3-D Matrix Ltd
13.1.1 3-D Matrix Ltd Company Information
13.1.2 3-D Matrix Ltd Topical Absorbable Hemostat Product Portfolios and Specifications
13.1.3 3-D Matrix Ltd Topical Absorbable Hemostat Sales, Revenue, Price and Gross Margin (2018-2023)
13.1.4 3-D Matrix Ltd Main Business Overview
13.1.5 3-D Matrix Ltd Latest Developments
13.2 Angiotech Pharmaceuticals Inc
13.2.1 Angiotech Pharmaceuticals Inc Company Information
13.2.2 Angiotech Pharmaceuticals Inc Topical Absorbable Hemostat Product Portfolios and Specifications
13.2.3 Angiotech Pharmaceuticals Inc Topical Absorbable Hemostat Sales, Revenue, Price and Gross Margin (2018-2023)
13.2.4 Angiotech Pharmaceuticals Inc Main Business Overview
13.2.5 Angiotech Pharmaceuticals Inc Latest Developments
13.3 Anika Therapeutics Inc
13.3.1 Anika Therapeutics Inc Company Information
13.3.2 Anika Therapeutics Inc Topical Absorbable Hemostat Product Portfolios and Specifications
13.3.3 Anika Therapeutics Inc Topical Absorbable Hemostat Sales, Revenue, Price and Gross Margin (2018-2023)
13.3.4 Anika Therapeutics Inc Main Business Overview
13.3.5 Anika Therapeutics Inc Latest Developments
13.4 APRUS Bio-Medical Innovations Pvt Ltd
13.4.1 APRUS Bio-Medical Innovations Pvt Ltd Company Information
13.4.2 APRUS Bio-Medical Innovations Pvt Ltd Topical Absorbable Hemostat Product Portfolios and Specifications
13.4.3 APRUS Bio-Medical Innovations Pvt Ltd Topical Absorbable Hemostat Sales, Revenue, Price and Gross Margin (2018-2023)
13.4.4 APRUS Bio-Medical Innovations Pvt Ltd Main Business Overview
13.4.5 APRUS Bio-Medical Innovations Pvt Ltd Latest Developments
13.5 Arch Therapeutics Inc
13.5.1 Arch Therapeutics Inc Company Information
13.5.2 Arch Therapeutics Inc Topical Absorbable Hemostat Product Portfolios and Specifications
13.5.3 Arch Therapeutics Inc Topical Absorbable Hemostat Sales, Revenue, Price and Gross Margin (2018-2023)
13.5.4 Arch Therapeutics Inc Main Business Overview
13.5.5 Arch Therapeutics Inc Latest Developments
13.6 Baxter
13.6.1 Baxter Company Information
13.6.2 Baxter Topical Absorbable Hemostat Product Portfolios and Specifications
13.6.3 Baxter Topical Absorbable Hemostat Sales, Revenue, Price and Gross Margin (2018-2023)
13.6.4 Baxter Main Business Overview
13.6.5 Baxter Latest Developments
13.7 C.R. Bard
13.7.1 C.R. Bard Company Information
13.7.2 C.R. Bard Topical Absorbable Hemostat Product Portfolios and Specifications
13.7.3 C.R. Bard Topical Absorbable Hemostat Sales, Revenue, Price and Gross Margin (2018-2023)
13.7.4 C.R. Bard Main Business Overview
13.7.5 C.R. Bard Latest Developments
13.8 Cellphire Inc
13.8.1 Cellphire Inc Company Information
13.8.2 Cellphire Inc Topical Absorbable Hemostat Product Portfolios and Specifications
13.8.3 Cellphire Inc Topical Absorbable Hemostat Sales, Revenue, Price and Gross Margin (2018-2023)
13.8.4 Cellphire Inc Main Business Overview
13.8.5 Cellphire Inc Latest Developments
13.9 Covalon Technologies Ltd
13.9.1 Covalon Technologies Ltd Company Information
13.9.2 Covalon Technologies Ltd Topical Absorbable Hemostat Product Portfolios and Specifications
13.9.3 Covalon Technologies Ltd Topical Absorbable Hemostat Sales, Revenue, Price and Gross Margin (2018-2023)
13.9.4 Covalon Technologies Ltd Main Business Overview
13.9.5 Covalon Technologies Ltd Latest Developments
13.10 Cresilon Inc
13.10.1 Cresilon Inc Company Information
13.10.2 Cresilon Inc Topical Absorbable Hemostat Product Portfolios and Specifications
13.10.3 Cresilon Inc Topical Absorbable Hemostat Sales, Revenue, Price and Gross Margin (2018-2023)
13.10.4 Cresilon Inc Main Business Overview
13.10.5 Cresilon Inc Latest Developments
13.11 Endomedix Incorporated
13.11.1 Endomedix Incorporated Company Information
13.11.2 Endomedix Incorporated Topical Absorbable Hemostat Product Portfolios and Specifications
13.11.3 Endomedix Incorporated Topical Absorbable Hemostat Sales, Revenue, Price and Gross Margin (2018-2023)
13.11.4 Endomedix Incorporated Main Business Overview
13.11.5 Endomedix Incorporated Latest Developments
13.12 Entegrion Inc
13.12.1 Entegrion Inc Company Information
13.12.2 Entegrion Inc Topical Absorbable Hemostat Product Portfolios and Specifications
13.12.3 Entegrion Inc Topical Absorbable Hemostat Sales, Revenue, Price and Gross Margin (2018-2023)
13.12.4 Entegrion Inc Main Business Overview
13.12.5 Entegrion Inc Latest Developments
13.13 Ethicon
13.13.1 Ethicon Company Information
13.13.2 Ethicon Topical Absorbable Hemostat Product Portfolios and Specifications
13.13.3 Ethicon Topical Absorbable Hemostat Sales, Revenue, Price and Gross Margin (2018-2023)
13.13.4 Ethicon Main Business Overview
13.13.5 Ethicon Latest Developments
13.14 ETX Pharma Inc
13.14.1 ETX Pharma Inc Company Information
13.14.2 ETX Pharma Inc Topical Absorbable Hemostat Product Portfolios and Specifications
13.14.3 ETX Pharma Inc Topical Absorbable Hemostat Sales, Revenue, Price and Gross Margin (2018-2023)
13.14.4 ETX Pharma Inc Main Business Overview
13.14.5 ETX Pharma Inc Latest Developments
13.15 Gelita
13.15.1 Gelita Company Information
13.15.2 Gelita Topical Absorbable Hemostat Product Portfolios and Specifications
13.15.3 Gelita Topical Absorbable Hemostat Sales, Revenue, Price and Gross Margin (2018-2023)
13.15.4 Gelita Main Business Overview
13.15.5 Gelita Latest Developments
13.16 Pfizer
13.16.1 Pfizer Company Information
13.16.2 Pfizer Topical Absorbable Hemostat Product Portfolios and Specifications
13.16.3 Pfizer Topical Absorbable Hemostat Sales, Revenue, Price and Gross Margin (2018-2023)
13.16.4 Pfizer Main Business Overview
13.16.5 Pfizer Latest Developments
14 Research Findings and Conclusion